Advanced Pharmacology NURS – 95 Exam Questions on Pharmacodynamics, Pharmacokinetics, Hypertension & Cardiovascular Drugs

This document contains approximately 95 multiple-choice exam questions with verified answers covering advanced pharmacology concepts for NURS 6521. The material comprehensively reviews pharmacokinetics and pharmacodynamics, including drug absorption, distribution, metabolism, elimination, receptor interactions, agonists and antagonists, competitive and allosteric inhibition, efficacy, potency, EC50, ED50, Kd, spare receptors, bioavailability, lipophilicity, blood–brain barrier penetration, and prodrug activation mechanisms. The content also provides in-depth clinical applications related to cardiovascular and antihypertensive pharmacotherapy, including ACE inhibitors, beta-blockers, calcium channel blockers (dihydropyridine and non-dihydropyridine), angiotensin receptor blockers, diuretics (spironolactone, furosemide, thiazides), management of proteinuria, post-myocardial infarction therapy, angina treatment classes, reflex tachycardia, and mechanisms of drugs such as minoxidil and naloxone. Additional emphasis is placed on receptor physiology, G-protein coupled receptors, second messengers such as cAMP, drug selectivity, maximal efficacy, and adverse pharmacologic responses. This resource is especially relevant for: • NURS 6521 Advanced Pharmacology courses • MSN and DNP nursing students • Nurse practitioner students preparing for pharmacology exams • Advanced practice registered nurse (APRN) certification preparation • Healthcare professionals reviewing cardiovascular pharmacotherapy The material aligns closely with commonly used advanced pharmacology textbooks such as Pharmacology for Nursing Care by Lehne and Goodman & Gilman’s The Pharmacological Basis of Therapeutics, particularly chapters addressing pharmacodynamics, receptor theory, antihypertensive therapy, and cardiovascular drug mechanisms. Keywords: pharmacodynamics, pharmacokinetics, bioavailability, receptor binding, agonist and antagonist, competitive inhibition, allosteric modulation, EC50, ED50, dissociation constant Kd, spare receptors, lipophilicity, blood brain barrier, ACE inhibitors, beta blockers, calcium channel blockers, dihydropyridine drugs, reflex tachycardia, angina pharmacotherapy, antihypertensive therapy, naloxone mechanism, G protein coupled receptor